Cargando…

Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children

OBJECTIVES: Obesity in children can lead to morbidity and mortality due to metabolic and inflammatory comorbidities. AIMS: The objective of the study was to investigate the alterations in acute inflammatory markers, serum amyloid P (SAP) and cortisol, and endocrine markers, leptin and insulin, in ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anwer, Mehwish, Iqbal, Muhammad J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166555/ https://www.ncbi.nlm.nih.gov/pubmed/30294581 http://dx.doi.org/10.4103/ijem.IJEM_66_18

Ejemplares similares

Editorial: Neurological, psychological and endocrine markers of eating disorders and obesity
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

S100β as a serum marker in endocrine resistant breast cancer
por: Charmsaz, Sara, et al.
Publicado: (2017)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

Markers of endocrine sensitivity
por: Hayes, Daniel F
Publicado: (2008)

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
por: Bodin, Karl, et al.
Publicado: (2010)

Endocrine Disruptors and Obesity
por: Darbre, Philippa D.
Publicado: (2017)

Serum amyloid P inhibits granulocyte adhesion
por: Maharjan, Anu S, et al.
Publicado: (2013)

Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis
por: Lakota, Katja, et al.
Publicado: (2015)

The Development of Serum Amyloid P as a Possible Therapeutic
por: Pilling, Darrell, et al.
Publicado: (2018)

Serum biomarkers for the prediction and diagnosis of preeclampsia: A meta-analysis
por: Shahid, Ruqaiya, et al.
Publicado: (2021)

Amyloid A in Serum and Ascitic Fluid as a Novel Diagnostic Marker of Spontaneous Bacterial Peritonitis
por: Badawi, Rehab, et al.
Publicado: (2020)

Serum amyloid P component: a new biomarker for low sperm concentration?
por: Sonesson, Annika, et al.
Publicado: (2021)

Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS
por: Daghestani, Mazin H., et al.
Publicado: (2021)

Acute-Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice
por: Scheja, Ludger, et al.
Publicado: (2008)

Erectile dysfunction as a marker of endocrine and glycemic disorders
por: Mazzilli, R., et al.
Publicado: (2022)

Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis
por: Dev, Sharad, et al.
Publicado: (2019)

Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Obesity and endocrine-disrupting chemicals
por: Amato, Angelica Amorim, et al.
Publicado: (2021)

Endocrine comorbidities of pediatric obesity
por: Lee, Jieun, et al.
Publicado: (2021)

First Identification of Resident and Circulating Fibrocytes in Dupuytren’s Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex
por: Iqbal, Syed Amir, et al.
Publicado: (2014)

Elevated Serum Gamma-Glutamyltransferase Is a Strong Marker of Insulin Resistance in Obese Children
por: Lee, Seon Yeong, et al.
Publicado: (2013)

Dementia in the older population is associated with neocortex content of serum amyloid P component
por: Ellmerich, Stephan, et al.
Publicado: (2021)

Serum Amyloid A Levels and Severity of COVID-19 in Children
por: Tasar, Selin, et al.
Publicado: (2023)

Evaluation of Serum Amyloid A as a Marker of Persistent Inflammation in Patients with Rheumatoid Arthritis
por: Agilli, Mehmet, et al.
Publicado: (2015)

Equine Inflammatory Markers in the Twenty-First Century: A Focus on Serum Amyloid A
por: Long, Alicia, et al.
Publicado: (2020)

Serum amyloid A in children and adolescents: association with overweight and carotid intima-media thickness
por: Barbosa, Maria Vitória Mareschi, et al.
Publicado: (2023)

Associations between Serum Apelin-12 Levels and Obesity-Related Markers in Chinese Children
por: Ba, Hong-Jun, et al.
Publicado: (2014)

Serum Calprotectin and Chemerin Concentrations as Markers of Low-Grade Inflammation in Prepubertal Children with Obesity
por: Rowicka, Grażyna, et al.
Publicado: (2020)

Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients
por: Shirai, Kumiko, et al.
Publicado: (2022)

The Paradoxical Effects of Serum Amyloid-P Component on Disseminated Candidiasis
por: Klotz, Stephen A., et al.
Publicado: (2022)

Serum Amyloid A in lung transplantation
por: Vietri, Lucia, et al.
Publicado: (2020)

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
por: Al-Shawi, Raya, et al.
Publicado: (2016)

Relationship Between Serum Amyloid A1 (SAA1) Gene Polymorphisms Studies with Obesity in the Saudi Population
por: Alharbi, Khalid Khalaf, et al.
Publicado: (2021)

Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children
por: Kłusek-Oksiuta, Monika, et al.
Publicado: (2014)

Sarcopenic Obesity and Endocrinal Adaptation with Age
por: Sakuma, Kunihiro, et al.
Publicado: (2013)

Childhood obesity and endocrine disrupting chemicals
por: Kim, Jin Taek, et al.
Publicado: (2017)

Causes of short stature in Pakistani children found at an Endocrine Center
por: Jawa, Ali, et al.
Publicado: (2016)

A unique biofilm in human deep mycoses: fungal amyloid is bound by host serum amyloid P component
por: Garcia-Sherman, Melissa C, et al.
Publicado: (2015)

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever
por: Lofty, Hala M., et al.
Publicado: (2016)

Endocrine pancreatic development: impact of obesity and diet
por: O'Dowd, Jacqueline F., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fcvon5ks2uhclemlg1mjh0ccq7